134 related articles for article (PubMed ID: 3666014)
1. Apomorphine decreases stimulated dopamine release in rat nucleus accumbens but not in neostriatum: in vivo voltammetric data.
Stamford JA; Kruk ZL; Millar J
Eur J Pharmacol; 1987 Jul; 139(3):363-4. PubMed ID: 3666014
[No Abstract] [Full Text] [Related]
2. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
Ichikawa J; Meltzer HY
Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
[TBL] [Abstract][Full Text] [Related]
3. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
Stamford JA; Kruk ZL; Millar J
Br J Pharmacol; 1991 Jan; 102(1):45-50. PubMed ID: 1675147
[TBL] [Abstract][Full Text] [Related]
5. Effects of systemic L-tyrosine on dopamine release from rat corpus striatum and nucleus accumbens.
During MJ; Acworth IN; Wurtman RJ
Brain Res; 1988 Jun; 452(1-2):378-80. PubMed ID: 3401745
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats.
Yamada S; Yokoo H; Nishi S
Brain Res; 1994 Jun; 648(1):176-9. PubMed ID: 7922522
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
Stoof JC; Verheijden PF; Leysen JE
Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
[TBL] [Abstract][Full Text] [Related]
8. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives.
Gundlach AL; Christie MJ; Beart PM
Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029
[TBL] [Abstract][Full Text] [Related]
9. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis.
Ichikawa J; Meltzer HY
Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
11. A thyrotropin releasing hormone analog, DN-1417, increases endogenous dopamine release from slices of rat striatum and nucleus accumbens.
Yamada S; Kojima H; Tsutsumi T; Nakamura J; Anraku S; Nishi S; Inanaga K
Kurume Med J; 1983; 30 Suppl():S29-35. PubMed ID: 6434800
[No Abstract] [Full Text] [Related]
12. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens.
Merchant KM; Gibb JW; Hanson GR
Eur J Pharmacol; 1989 Feb; 160(3):409-12. PubMed ID: 2565819
[TBL] [Abstract][Full Text] [Related]
13. Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.
Stamford JA; Kruk ZL; Millar J
Br J Pharmacol; 1988 Jul; 94(3):924-32. PubMed ID: 2902896
[TBL] [Abstract][Full Text] [Related]
14. Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens.
Missale C; Castelletti L; Govoni S; Spano PF; Trabucchi M; Hanbauer I
J Neurochem; 1985 Jul; 45(1):51-6. PubMed ID: 3998732
[TBL] [Abstract][Full Text] [Related]
15. Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum.
Henselmans JM; Stoof JC
Brain Res; 1991 Dec; 566(1-2):1-7. PubMed ID: 1687661
[TBL] [Abstract][Full Text] [Related]
16. Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.
de Belleroche J; Gardiner IM
J Neural Transm; 1983; 58(3-4):153-68. PubMed ID: 6141217
[TBL] [Abstract][Full Text] [Related]
17. The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitro.
Radhakishun FS; Stoof JC; Mulder AH; Versteeg DH; van Ree JM
Brain Res; 1987 Nov; 426(2):235-42. PubMed ID: 2961411
[TBL] [Abstract][Full Text] [Related]
18. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action.
Lane RF; Blaha CD
Brain Res Bull; 1987 Jan; 18(1):135-8. PubMed ID: 3828839
[TBL] [Abstract][Full Text] [Related]
19. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis.
Blaha CD; Coury A; Fibiger HC; Phillips AG
Neuroscience; 1990; 34(3):699-705. PubMed ID: 2352647
[TBL] [Abstract][Full Text] [Related]
20. Stimulated limbic and striatal dopamine release measured by fast cyclic voltammetry: anatomical, electrochemical and pharmacological characterisation.
Stamford JA; Kruk ZL; Millar J
Brain Res; 1988 Jun; 454(1-2):282-8. PubMed ID: 3261616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
